Kristina Shea is one of the original team members of Rapid Dose Therapeutics, senior marketing executive, single mother, and a medical cannabis patient herself. Kristina is a passionate advocate — with a mission to support ending stigma that surrounds cannabis use. She is also a proud feminist supporting inclusivity within corporations for equal representation in leadership roles and a voice at the table.
Kristina has a personal medical story — she suffered from a serious brain cyst resulting in debilitating migraines and subsequent health conditions — including the undesired side-effects from pharmaceutical pain killers. Kristina then discovered the medical benefits of cannabis — as a non-smoker, she saw the need for convenient, precisely dosed, non-inhalation, delivery system other than smoking or vaping that provided a rapid uptake. This prompted her journey with Rapid Dose Therapeutics (RDT).
Rapid Dose is a Canadian life sciences consumer-centric company providing innovative, proprietary drug delivery technologies designed to improve consumer and patient outcomes – and to enhance quality of life. RDT’s flagship product QuickStrip™ is an oral dissolvable film delivery system (via sublingual or buccal) — providing a discreet and Smoke-Free Choice™ for cannabis consumers. The QuickStrip™ med-tech is virtually unlimited from nutraceutical, wellness and pharmaceutical applications.
No Smoke. No Smell. No Stigma™ solution.
Kristina now shares her personal story and educates the public on the smoke-free delivery system, to support the normalization and education of medical cannabis applications. To learn more about Rapid Dose Therapeutics, www.QuickStrip.life and www.rapid-dose.com.
RDT is public on the CSE: DOSE.